In this episode of the NIH All About Grants podcast, Deysi Duque, a Senior Clinical Trials Analyst within the NIH Office of Extramural Research, talks us through the clinical trials dissemination policy, its purpose, resources, exceptions, and what recipient organizations and researchers should know to ensure compliance.
The modernized ClinicalTrials.gov website has an updated design that is visually appealing and easy to read.
What should researchers and recipients be aware of regarding ClinicalTrials.gov as it relates to reporting NIH grant-funded trials? Join us for this episode of the NIH All About Grants podcast to hear from Dr. Anna Fine, the Acting Director of ClinicalTrials.gov.
In June 2023, we will reach an important milestone: replacing the current website with the modernized ClinicalTrials.gov website. This modernized site will implement the innovations we have designed based on user feedback, including an updated look and feel and improved functionality for searching, viewing, and downloading information about clinical trials.
To assess our progress with results information submission to ClinicalTrials.gov beyond 2020, we conducted analyses of NIH-grant-funded clinical trials for which main results were due in fiscal year (FY) 2020, FY 2021 or FY 2022.
New Resources Available on Submitting Good Cause Extension Requests for Results Reporting to ClinicalTrials.gov
Do you have questions about when it’s allowable to request an extension of the deadline for submitting clinical trial results information to ClinicalTrials.gov, how to request an extension, what to include, and how the requests are evaluated? A recently published resource explains all this and more.
If you’re conducting research with human subjects, you might have questions about HHS regulations and NIH policies and how you can prepare proposals and inclusion plans. HHS and NIH experts address many of these questions, along with resources, guidance, and case studies in a 2-part webinar series focused on Human Subjects Research Policies, Clinical Trials, and Inclusion.
The White House Office of Science and Technology Policy (OSTP) and National Security council recently released a Request for Information seeking ideas on strengthening the national capacity of clinical trial infrastructure and emergency clinical trials.
The Project Outcomes section of the Research Performance Progress Report (RPPR) provides information about the cumulative outcomes or findings of the project. This information is made available to the public through NIH RePORTER, so take that into account when completing this section!
NIH supports Phase III trials to study how effective interventions are in large groups of people, comparing them to other standard or experimental interventions. We go deeper into these clinical trials and what you should know in our next edition of the NIH All About Grants podcast.